temozolomide

Generic: temozolomide

Labeler: ascend laboratories, llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name temozolomide
Generic Name temozolomide
Labeler ascend laboratories, llc
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

temozolomide 180 mg/1

Manufacturer
Ascend Laboratories, LLC

Identifiers & Regulatory

Product NDC 67877-541
Product ID 67877-541_f519f4f0-bb62-43cb-bfc2-15f00ac1aad3
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA207658
Listing Expiration 2026-12-31
Marketing Start 2017-04-28

Pharmacologic Class

Established (EPC)
alkylating drug [epc]
Mechanism of Action
alkylating activity [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 67877541
Hyphenated Format 67877-541

Supplemental Identifiers

RxCUI
313209 313210 313211 317160 700883 700885
UNII
YF1K15M17Y
NUI
N0000000236 N0000175558

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name temozolomide (source: ndc)
Generic Name temozolomide (source: ndc)
Application Number ANDA207658 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 180 mg/1
source: ndc
Packaging
  • 5 CAPSULE in 1 BOTTLE (67877-541-07)
  • 14 CAPSULE in 1 BOTTLE (67877-541-14)
source: ndc

Packages (2)

67877-541-07 5 CAPSULE in 1 BOTTLE (67877-541-07) 67877-541-14 14 CAPSULE in 1 BOTTLE (67877-541-14)

Ingredients (1)

temozolomide (180 mg/1)

Linked Drug Pages (1)

Temozolomide ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "f519f4f0-bb62-43cb-bfc2-15f00ac1aad3", "openfda": {"nui": ["N0000000236", "N0000175558"], "unii": ["YF1K15M17Y"], "rxcui": ["313209", "313210", "313211", "317160", "700883", "700885"], "spl_set_id": ["33d67bce-38ae-45fc-a858-d51167b0ecfd"], "pharm_class_epc": ["Alkylating Drug [EPC]"], "pharm_class_moa": ["Alkylating Activity [MoA]"], "manufacturer_name": ["Ascend Laboratories, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "5 CAPSULE in 1 BOTTLE (67877-541-07)", "package_ndc": "67877-541-07", "marketing_start_date": "20170428"}, {"sample": false, "description": "14 CAPSULE in 1 BOTTLE (67877-541-14)", "package_ndc": "67877-541-14", "marketing_start_date": "20170428"}], "brand_name": "Temozolomide", "product_id": "67877-541_f519f4f0-bb62-43cb-bfc2-15f00ac1aad3", "dosage_form": "CAPSULE", "pharm_class": ["Alkylating Activity [MoA]", "Alkylating Drug [EPC]"], "product_ndc": "67877-541", "generic_name": "Temozolomide", "labeler_name": "Ascend Laboratories, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Temozolomide", "active_ingredients": [{"name": "TEMOZOLOMIDE", "strength": "180 mg/1"}], "application_number": "ANDA207658", "marketing_category": "ANDA", "marketing_start_date": "20170428", "listing_expiration_date": "20261231"}